TABLE 3.
Disease (n) | Controls (n) | Casp9 Measured | Detection Method | Tissue Examined | Pathological Casp9 Localization | Ref. |
---|---|---|---|---|---|---|
RD (4) | Normal (10) | Unspecified cl-casp9 | IHC | Retina (postmortem) | Photoreceptors | Hisatomi et al. (2008) |
RRD (33) | -- | D315 cl-casp9 | Immunoassay | Subretinal fluid | -- | Carpineto et al. (2016) |
T2D (10) | Normal (10) | Unspecified cl-casp9 | IHC | Retina (postmortem) | Ganglion cell layer | Oshitari et al. (2008) |
Glaucoma (10–38) | Normal (10–30) | Unspecified cl-casp9 | LC-MS/MS, Western blot, IHC | Retina (postmortem) | Ganglion cells | Yang et al. (2011) |
RD, Retinal detachment; RRD, rhegmatogenous retinal detachment; T2D, Type 2 diabetes.